Innover, c’est créer. Commercialiser, c’est réussir
L’innovation suisse en péril
«La Suisse doit former davantage de médecins et d’ingénieurs»
FIF Funding for four Geneva-based technology ventures
CE Mark approval paves the way for Aspivix global commercialisation
Soleva passed all the road compatibility tests with their autonomous solar van
The Alzheimer’s Drug Discovery Foundation (ADDF) invests $4.2M in GliaPharm to advance its lead program
